Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival

被引:9
作者
Xu, Shao-jun [1 ]
Zhang, Si-yu [2 ]
Dong, Ling-yi [2 ]
Lin, Guo-sheng [1 ]
Zhou, Yong-jian [1 ]
机构
[1] Fujian Med Univ, Dept Gastr Surg, Union Hosp, 29 Xin Quan Rd, Fuzhou 350001, Fujian, Peoples R China
[2] Xiamen Univ, Dept Gen Surg, Affiliated Hosp 1, Xiamen, Peoples R China
关键词
Gastrointestinal stromal tumors; Conditional survival; Chinese patients; Prognosis; Surgery; DISEASE-FREE SURVIVAL; MULTIINSTITUTIONAL ANALYSIS; SURGICAL RESECTION; ADJUVANT IMATINIB; HIGH-RISK; CARCINOMA; RECURRENCE; MESYLATE; THERAPY; CANCER;
D O I
10.1186/s12885-021-08828-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The prognosis of patients with gastrointestinal stromal tumors (GISTs) is generally evaluated at the time of diagnosis but does not reflect the survival dynamics of patients in the future. Therefore, the purpose of this article was to evaluate the conditional survival (CS) of Chinese patients with GISTs after radical resection. Methods This retrospective study included 451 patients who underwent radical surgery for GISTs. A Cox proportional hazard model was used to evaluate the prognostic factors of disease-free survival (DFS). The 3-year conditional DFS (CDFS3) of patients who survived for x years was expressed as CDFS3=DFS(x + 3)/DFS(x). Results The traditional 3-year DFS rate decreased gradually from 94.0% at 3 years to 77.3% at 7 years, while the CDFS3 rate increased from 94.0 to 95.2% over the survival time of the patients. In addition, classic clinicopathological prognostic factors had different effects on CDFS3, with changes observed in survival time, but these effects were only slight or moderate (|d|<0.5). Although multivariate analysis showed that age, sex, mitotic index and tumor rupture were independent risk factors for DFS at baseline, all adverse prognostic factors, except for the mitotic index, lost their predictive significance at 5 years after operation. When the Modified NIH criteria were included, the risk staging was found to be an independent risk factor for recurrence or death. Time-dependent Cox regression analysis showed that the modified NIH criteria independently affected the recurrence or death of GIST patients within 2 years after operation. Conclusion CS provides detailed dynamic survival information about Chinese patients with primary resected GISTs. The mitotic index is of great clinical significance for the monitoring and follow-up of patient populations with a high risk of tumor recurrence or death until 5 years after surgery.
引用
收藏
页数:10
相关论文
共 31 条
  • [1] Conditional Disease-Free Survival After Surgical Resection of Gastrointestinal Stromal Tumors A Multi-institutional Analysis of 502 Patients
    Bischof, Danielle A.
    Kim, Yuhree
    Dodson, Rebecca
    Jimenez, M. Carolina
    Behman, Ramy
    Cocieru, Andrei
    Fisher, Sarah B.
    Groeschl, Ryan T.
    Squires, Malcolm H., III
    Maithel, Shishir K.
    Blazer, Dan G., III
    Kooby, David A.
    Gamblin, T. Clark
    Bauer, Todd W.
    Quereshy, Fayez A.
    Karanicolas, Paul J.
    Law, Calvin H. L.
    Pawlik, Timothy M.
    [J]. JAMA SURGERY, 2015, 150 (04) : 299 - 306
  • [2] INDEXES AND BOUNDARIES FOR QUANTITATIVE SIGNIFICANCE IN STATISTICAL DECISIONS
    BURNAND, B
    KERNAN, WN
    FEINSTEIN, AR
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (12) : 1273 - 1284
  • [3] Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial
    Corless, Christopher L.
    Ballman, Karla V.
    Antonescu, Cristina R.
    Kolesnikova, Violetta
    Maki, Robert G.
    Pisters, Peter W. T.
    Blackstein, Martin E.
    Blanke, Charles D.
    Demetri, George D.
    Heinrich, Michael C.
    von Mehren, Margaret
    Patel, Shreyaskumar
    McCarter, Martin D.
    Owzar, Kouros
    DeMatteo, Ronald P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15) : 1563 - U61
  • [4] Gastrointestinal stromal tumours: origin and molecular oncology
    Corless, Christopher L.
    Barnett, Christine M.
    Heinrich, Michael C.
    [J]. NATURE REVIEWS CANCER, 2011, 11 (12) : 865 - 878
  • [5] Conditional Survival after Hepatic Resection for Hepatocellular Carcinoma in Cirrhotic Patients
    Cucchetti, Alessandro
    Piscaglia, Fabio
    Cescon, Matteo
    Ercolani, Giorgio
    Terzi, Eleonora
    Bolondi, Luigi
    Zanello, Matteo
    Pinna, Antonio D.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4397 - 4405
  • [6] Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour
    D'Ambrosio, Lorenzo
    Palesandro, Erica
    Boccone, Paola
    Tolomeo, Francesco
    Miano, Sara
    Galizia, Danilo
    Manca, Antonio
    Chiara, Gabriele
    Bertotto, Ilaria
    Russo, Filippo
    Campanella, Delia
    Venesio, Tiziana
    Sangiolo, Dario
    Pignochino, Ymera
    Siatis, Dimitrios
    De Simone, Michele
    Ferrero, Alessandro
    Pisacane, Alberto
    Tos, Angelo Paolo Dei
    Aliberti, Sandra
    Aglietta, Massimo
    Grignani, Giovanni
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 78 : 122 - 132
  • [7] Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)
    DeMatteo, Ronald P.
    Gold, Jason S.
    Saran, Lisa
    Goenen, Mithat
    Liau, Kui Hin
    Maki, Robert G.
    Singer, Samuel
    Besmer, Peter
    Brennan, Murray F.
    Antonescu, Cristina R.
    [J]. CANCER, 2008, 112 (03) : 608 - 615
  • [8] Long-term Results of Adjuvant Imatinib Mesylate in Localized, High-Risk, Primary Gastrointestinal Stromal Tumor ACOSOG Z9000 (Alliance) Intergroup Phase 2 Trial
    DeMatteo, Ronald P.
    Ballman, Karla V.
    Antonescu, Cristina R.
    Corless, Christopher
    Kolesnikova, Violetta
    von Mehren, Margaret
    McCarter, Martin D.
    Norton, Jeffrey
    Maki, Robert G.
    Pisters, Peter W. T.
    Demetri, George D.
    Brennan, Murray F.
    Owzar, Kouros
    [J]. ANNALS OF SURGERY, 2013, 258 (03) : 422 - 429
  • [9] Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
    Ducimetiere, Francoise
    Lurkin, Antoine
    Ranchere-Vince, Dominique
    Decouvelaere, Anne-Valerie
    Peoc'h, Michel
    Istier, Luc
    Chalabreysse, Philippe
    Muller, Christine
    Alberti, Laurent
    Bringuier, Pierre-Paul
    Scoazec, Jean-Yves
    Schott, Anne-Marie
    Bergeron, Christophe
    Cellier, Dominic
    Blay, Jean-Yves
    Ray-Coquard, Isabelle
    [J]. PLOS ONE, 2011, 6 (08):
  • [10] Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: Analysis of results in 140 surgically resected patients
    Yoshiya Fujimoto
    Yukihiro Nakanishi
    Kimio Yoshimura
    Tadakazu Shimoda
    [J]. Gastric Cancer, 2003, 6 (1) : 39 - 48